Related Experiment Video
Updated: Mar 25, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Connective tissue diseases, multimorbidity and the ageing lung
Paolo Spagnolo1, Jean-François Cordier2, Vincent Cottin3
1Medical University Clinic, Canton Hospital Baselland, and University of Basel, Liestal, Switzerland.
Connective tissue diseases (CTDs) increasingly affect the elderly, often causing lung complications like interstitial lung disease. Improved understanding and tailored guidelines are crucial for managing CTDs in older adults.
Area of Science:
- Rheumatology
- Pulmonology
- Geriatrics
Background:
- Connective tissue diseases (CTDs) involve immune-mediated inflammation, tissue damage, and potential organ dysfunction.
- Lung involvement, particularly interstitial lung disease (ILD) and pulmonary hypertension, is a frequent and serious complication of CTDs, especially systemic sclerosis.
- The prevalence of CTDs is rising in the elderly due to increased life expectancy and improved treatments.
Purpose of the Study:
- To highlight the growing concern of connective tissue diseases in the elderly population.
- To emphasize the challenges in managing CTDs in geriatric patients due to comorbidities and treatment complications.
- To underscore the need for better understanding of immune regulation in the elderly and for specialized evidence-based guidelines.
Main Methods:
- Review of current literature on connective tissue diseases in the elderly.
- Analysis of the impact of age-related comorbidities and treatment complications.
- Identification of knowledge gaps in geriatric rheumatology and pulmonology.
Main Results:
- Connective tissue diseases in the elderly are associated with significant morbidity and mortality.
- Age-related comorbidities and treatment complexities complicate management decisions.
- There is a need for specific guidelines tailored to the geriatric population.
Conclusions:
- Connective tissue diseases in the elderly present a growing challenge for healthcare providers and health resources.
- Improved understanding of immune system regulation in aging is essential.
- Development of evidence-based guidelines for elderly patients is critical for optimizing CTD management.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
The Effect of Aging on Tissues
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Introduction to Connective Tissues
